e-learning
resources
Vienna 2003
Sunday 28.09.2003
Developments and applications with exhaled breath condensate and exhaled air
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Methodological aspects of exhaled prostanoid measurements
P. Montuschi, F. Varone, S. Valente, D. Spina, C. Mondino, G. Ciappi, G. Ciabattoni (Rome, Chieti, Italy)
Source:
Annual Congress 2003 - Developments and applications with exhaled breath condensate and exhaled air
Session:
Developments and applications with exhaled breath condensate and exhaled air
Session type:
Oral Presentation
Number:
250
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Montuschi, F. Varone, S. Valente, D. Spina, C. Mondino, G. Ciappi, G. Ciabattoni (Rome, Chieti, Italy). Methodological aspects of exhaled prostanoid measurements. Eur Respir J 2003; 22: Suppl. 45, 250
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Early detection of lung cancer in exhaled breath condensate using miRNA markers
Is snoring the cause of oxidative stress in airways in obstructive sleep apnea patients?
FEV
1
dynamics and total NO
3
-/ NO
2
- level in exhaled breath condensate of current smokers
Related content which might interest you:
Methodological aspects of the measurement of exhaled NO level
Source: Eur Respir J 2006; 28: Suppl. 50, 727s
Year: 2006
Methodological improvements for measuring eicosanoids and cytokines in exhaled breath condensate
Source: Eur Respir J 2005; 26: Suppl. 49, 372s
Year: 2005
Measurement of exhaled breath samples using an electronic nose: methodological issues
Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function?
Year: 2009
Technical problems with measurements of biomarkers - exhaled nitric oxide
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017
Exhaled nitric oxide in childhood asthma: methodological issues and clinical applications
Source: Eur Respir Rev 2006; 15: 215-217
Year: 2006
Technical problems with measurements of biomarkers - exhaled breath condensate
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017
Clinical evaluation of exhaled nitric oxide measurement in monitoring childhood asthma
Source: Annual Congress 2010 - Functional assessment of paediatric lung disease
Year: 2010
Short-term repeatability of fractional exhaled nitric oxide (FENO) measurement in children
Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing
Year: 2016
Experiences of exhaled nitric oxide measurements in diagnostics of occupational asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 281s
Year: 2001
Off-line sampling of exhaled air for nitric oxide measurement in children: methodological aspects
Source: Eur Respir J 2001; 17: 898-903
Year: 2001
Reproducibility of the Vivatmopro measurements for exhaled nitric oxide values
Source: International Congress 2019 – Insights into physiological diagnostic services
Year: 2019
Validation of eicosanoid measurements in exhaled breath condensate
Source: Eur Respir J 2002; 20: Suppl. 38, 422s
Year: 2002
The assessment of exhaled nitric oxide fraction in monitoring asthma control: How to raise the clinical relevance?
Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Year: 2010
Long-term reproducibility of exhaled nitric oxide and exhaled breath temperature in healthy children
Source: Annual Congress 2013 –Clinical applications of respiratory physiology in children
Year: 2013
Measurement of exhaled breath temperature in science and clinical practice
Source: Breathe 2012; 8: 186-192
Year: 2012
Reproducibility of cysteinyl-leukotriene measurements in exhaled breath condensate in children
Source: Eur Respir J 2001; 18: Suppl. 33, 39s
Year: 2001
Improvement of asthma control assessed by exhaled nitric oxide: a real-life longitudinal study
Source: Eur Respir J 2005; 26: Suppl. 49, 276s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept